Cargando…

Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients

OBJECTIVE: To evaluate adherence to antihypertensive therapy (AHT) and the association between adherence to AHT, all-cause mortality, and cardiovascular (CV) morbidity in a large cohort of patients newly treated with antihypertensives in a clinical practice setting. METHODS: An administrative databa...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposti, Luca Degli, Saragoni, Stefania, Benemei, Silvia, Batacchi, Paolo, Geppetti, Pierangelo, Di Bari, Mauro, Marchionni, Niccolò, Sturani, Alessandra, Buda, Stefano, Esposti, Ezio Degli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169972/
https://www.ncbi.nlm.nih.gov/pubmed/21935332
http://dx.doi.org/10.2147/CEOR.S15619
_version_ 1782211559085309952
author Esposti, Luca Degli
Saragoni, Stefania
Benemei, Silvia
Batacchi, Paolo
Geppetti, Pierangelo
Di Bari, Mauro
Marchionni, Niccolò
Sturani, Alessandra
Buda, Stefano
Esposti, Ezio Degli
author_facet Esposti, Luca Degli
Saragoni, Stefania
Benemei, Silvia
Batacchi, Paolo
Geppetti, Pierangelo
Di Bari, Mauro
Marchionni, Niccolò
Sturani, Alessandra
Buda, Stefano
Esposti, Ezio Degli
author_sort Esposti, Luca Degli
collection PubMed
description OBJECTIVE: To evaluate adherence to antihypertensive therapy (AHT) and the association between adherence to AHT, all-cause mortality, and cardiovascular (CV) morbidity in a large cohort of patients newly treated with antihypertensives in a clinical practice setting. METHODS: An administrative database kept by the Local Health Unit of Florence (Italy) listing patient baseline characteristics, drug prescription, and hospital admission information was used to perform a population-based retrospective study including patients newly treated with antihypertensives, ≥18 years of age, with a first prescription between January 1, 2004 and December 31, 2006. Patients using antihypertensives for secondary prevention of CV disease, occasional spot users, and patients with early CV events, were excluded from the study cohort. Adherence to AHT was calculated and classified as poor, moderate, good, and excellent. A Cox regression model was conducted to determine the association among adherence to AHT and risk of all-cause mortality, stroke, or acute myocardial infarction. RESULTS: A total of 31,306 patients, 15,031 men (48.0%), and 16,275 women (52.0%), with a mean age of 60.2 ± 14.5 years was included in the study. Adherence to AHT was poor in 8038 patients (25.7% of included patients), moderate in 4640 (14.8%), good in 5651 (18.1%), and excellent in 12,977 (41.5%). Compared with patients with poor adherence (hazard ratio [HR] = 1), the risk of all-cause death, stroke, or acute myocardial infarction was significantly lower in patients with good (HR = 0.69, P < 0.001) and excellent adherence (HR = 0.53, P < 0.001). CONCLUSIONS: These findings indicate that suboptimal adherence to AHT occurs in a substantial proportion of patients and is associated with poor health outcomes already in primary prevention of CV diseases. For health authorities, this preliminary evidence underlines the need for monitoring and improving medication adherence in clinical practice.
format Online
Article
Text
id pubmed-3169972
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-31699722011-09-20 Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients Esposti, Luca Degli Saragoni, Stefania Benemei, Silvia Batacchi, Paolo Geppetti, Pierangelo Di Bari, Mauro Marchionni, Niccolò Sturani, Alessandra Buda, Stefano Esposti, Ezio Degli Clinicoecon Outcomes Res Review OBJECTIVE: To evaluate adherence to antihypertensive therapy (AHT) and the association between adherence to AHT, all-cause mortality, and cardiovascular (CV) morbidity in a large cohort of patients newly treated with antihypertensives in a clinical practice setting. METHODS: An administrative database kept by the Local Health Unit of Florence (Italy) listing patient baseline characteristics, drug prescription, and hospital admission information was used to perform a population-based retrospective study including patients newly treated with antihypertensives, ≥18 years of age, with a first prescription between January 1, 2004 and December 31, 2006. Patients using antihypertensives for secondary prevention of CV disease, occasional spot users, and patients with early CV events, were excluded from the study cohort. Adherence to AHT was calculated and classified as poor, moderate, good, and excellent. A Cox regression model was conducted to determine the association among adherence to AHT and risk of all-cause mortality, stroke, or acute myocardial infarction. RESULTS: A total of 31,306 patients, 15,031 men (48.0%), and 16,275 women (52.0%), with a mean age of 60.2 ± 14.5 years was included in the study. Adherence to AHT was poor in 8038 patients (25.7% of included patients), moderate in 4640 (14.8%), good in 5651 (18.1%), and excellent in 12,977 (41.5%). Compared with patients with poor adherence (hazard ratio [HR] = 1), the risk of all-cause death, stroke, or acute myocardial infarction was significantly lower in patients with good (HR = 0.69, P < 0.001) and excellent adherence (HR = 0.53, P < 0.001). CONCLUSIONS: These findings indicate that suboptimal adherence to AHT occurs in a substantial proportion of patients and is associated with poor health outcomes already in primary prevention of CV diseases. For health authorities, this preliminary evidence underlines the need for monitoring and improving medication adherence in clinical practice. Dove Medical Press 2011-03-07 /pmc/articles/PMC3169972/ /pubmed/21935332 http://dx.doi.org/10.2147/CEOR.S15619 Text en © 2011 Degli Esposti et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Esposti, Luca Degli
Saragoni, Stefania
Benemei, Silvia
Batacchi, Paolo
Geppetti, Pierangelo
Di Bari, Mauro
Marchionni, Niccolò
Sturani, Alessandra
Buda, Stefano
Esposti, Ezio Degli
Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients
title Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients
title_full Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients
title_fullStr Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients
title_full_unstemmed Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients
title_short Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients
title_sort adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169972/
https://www.ncbi.nlm.nih.gov/pubmed/21935332
http://dx.doi.org/10.2147/CEOR.S15619
work_keys_str_mv AT espostilucadegli adherencetoantihypertensivemedicationsandhealthoutcomesamongnewlytreatedhypertensivepatients
AT saragonistefania adherencetoantihypertensivemedicationsandhealthoutcomesamongnewlytreatedhypertensivepatients
AT benemeisilvia adherencetoantihypertensivemedicationsandhealthoutcomesamongnewlytreatedhypertensivepatients
AT batacchipaolo adherencetoantihypertensivemedicationsandhealthoutcomesamongnewlytreatedhypertensivepatients
AT geppettipierangelo adherencetoantihypertensivemedicationsandhealthoutcomesamongnewlytreatedhypertensivepatients
AT dibarimauro adherencetoantihypertensivemedicationsandhealthoutcomesamongnewlytreatedhypertensivepatients
AT marchionniniccolo adherencetoantihypertensivemedicationsandhealthoutcomesamongnewlytreatedhypertensivepatients
AT sturanialessandra adherencetoantihypertensivemedicationsandhealthoutcomesamongnewlytreatedhypertensivepatients
AT budastefano adherencetoantihypertensivemedicationsandhealthoutcomesamongnewlytreatedhypertensivepatients
AT espostieziodegli adherencetoantihypertensivemedicationsandhealthoutcomesamongnewlytreatedhypertensivepatients